Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flu Vaccine Production Soars, Setting Up Debate On Universal Recommendation

Executive Summary

Influenza vaccine production for the U.S. could reach 120 mil. doses for the 2006-2007 season based on manufacturers' estimates

You may also be interested in...



Novartis’ New Vaccine Division Takes On Evolving Market

Novartis' newly acquired vaccines unit will face an increasingly differentiated market for flu vaccines, Vaccine & Diagnostic Business CEO Jörg Reinhardt said

Novartis’ New Vaccine Division Takes On Evolving Market

Novartis' newly acquired vaccines unit will face an increasingly differentiated market for flu vaccines, Vaccine & Diagnostic Business CEO Jörg Reinhardt said

Accelerated Approval Gives Wings To Pandemic Flu Vaccine Development

FDA has unveiled a strategy for preventing influenza vaccine shortages and getting a jump on flu pandemics by using surrogate endpoints to accelerate approval of new vaccines

Related Content

UsernamePublicRestriction

Register

OM013658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel